Posted by on April 15, 2021 12:53 am
Originally From: Gaily Grind

Tags: , , ,

(adsbygoogle = window.adsbygoogle || []).push({});

More than 60 years after the first known case of human HIV infection, and 40 years after the beginning of the HIV/AIDS epidemic in the United States, a new vaccine has shown huge promise in the fight against HIV with the treatment successfully stimulating the production of antibodies in human trials.

In a Phase I Clinical trial that began in 2018, scientists at the International AIDS Vaccine Initiative (IAVI) and Scripps Research gave 48 participants two doses of either the vaccine candidate or a placebo, spaced two months apart.

Results show that, in 97 percent of recipients, the vaccine stimulated the immune system to produce immunoglobulin G (IgG) B cells—a first step to

READ MORE OF THIS POST AT The Gaily Grind

Leave a Reply

Your email address will not be published. Required fields are marked *

live cams now